Martin Widschwendter
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 21
- Cancer-related molecular mechanisms research 19
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 88
- Cancer-related gene regulation 20
- RNA modifications and cancer 18
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 28
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 21
- Oncology top 1%
-
- Estrogen and related hormone effects 16
- Co-authors
- Andrew E. TeschendorffHeidi FieglChristian MarthHannes MüllerPeter A. JonesHans H. GoebelAllison JonesElisabeth Müller‐Holzner
- Journals
- International Journal of Cancer (13 papers)British Journal of Cancer (9 papers)Cancer Research (8 papers)
- Partner nations
- United KingdomAustriaUnited States
In The Last Decade
Martin Widschwendter
179 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 2.5k
- Molecular Biology 7.6k
- Reproductive Medicine 915
- Obstetrics and Gynecology 633
- Oncology 2.1k
Countries citing papers authored by Martin Widschwendter
This map shows the geographic impact of Martin Widschwendter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Widschwendter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Widschwendter more than expected).
Fields of papers citing papers by Martin Widschwendter
This network shows the impact of papers produced by Martin Widschwendter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Widschwendter. The network helps show where Martin Widschwendter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Widschwendter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | Cervical cancer screening using DNA methylation triage in a real-world populationbreakdown → | 2024 | 44 |
| 8 | 2024 | 1 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 32 | |
| 11 | 2020 | 12 | |
| 12 | 2016 | 319 | |
| 13 | 2014 | 18 | |
| 14 | Differential methylation in PGR may explain varying progesterone levels in migrant Bangladeshi women | 2009 | 1 |
| 15 | CpG Island Methylator Phenotype in Human Colorectal Cancer Is Tightly Associated with BRAF Mutation and Underlies Sporadic Mismatch Repair Deficiency. | 2006 | 1 |
| 16 | 2005 | 208 | |
| 17 | 2004 | 268 | |
| 18 | 2004 | 100 | |
| 19 | 2004 | 186 | |
| 20 | Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K. | 2001 | 7 |
About Martin Widschwendter
Martin Widschwendter is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Cancer Research, Molecular Biology and Genetics, having authored 184 papers that have together received 10.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (88 papers), Ovarian cancer diagnosis and treatment (28 papers), Cancer Genomics and Diagnostics (21 papers), Endometrial and Cervical Cancer Treatments (21 papers), Cancer-related gene regulation (20 papers), Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (18 papers) and Estrogen and related hormone effects (16 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (7.6k citations), Reproductive Medicine (915 citations), Obstetrics and Gynecology (633 citations) and Oncology (2.1k citations). Martin Widschwendter has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Andrew E. Teschendorff, Heidi Fiegl, Christian Marth, Hannes Müller, Peter A. Jones, Hans H. Goebel, Allison Jones, Elisabeth Müller‐Holzner, Ian Jacobs and Andreas Widschwendter. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Cancer Research, PLoS ONE and Genome Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.